Noreen Roth Henig
2021
In 2021, Noreen Roth Henig earned a total compensation of $1.8M as Chief Medical Officer at Kezar Life Sciences, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $218,500 |
|---|---|
| Option Awards | $1,106,084 |
| Salary | $475,000 |
| Other | $12,032 |
| Total | $1,811,616 |
Henig received $1.1M in option awards, accounting for 61% of the total pay in 2021.
Henig also received $218.5K in non-equity incentive plan, $475K in salary and $12K in other compensation.
Rankings
In 2021, Noreen Roth Henig's compensation ranked 6,418th out of 12,415 executives tracked by ExecPay. In other words, Henig earned more than 48.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,418 out of 12,415 | 48th |
Division Manufacturing | 2,744 out of 5,505 | 50th |
Major group Chemicals And Allied Products | 1,211 out of 2,375 | 49th |
Industry group Drugs | 1,079 out of 2,096 | 49th |
Industry Pharmaceutical Preparations | 781 out of 1,546 | 50th |
Source: SEC filing on April 26, 2022.
Henig's colleagues
We found two more compensation records of executives who worked with Noreen Roth Henig at Kezar Life Sciences in 2021.